SARS-CoV-2 spike protein could be speeding up Alzheimer’s and other brain diseases, says new study

Swedish researchers find that SARS-CoV-2’s spike protein amyloids can accelerate the formation of harmful protein aggregates related to neurodegenerative diseases like Creutzfeldt-Jakob and Alzheimer’s. The study suggests a potential link between COVID-19 and increased cases of these brain disorders.

Smidt Heart Institute patient plans to climb Peru’s Machu Picchu after successful robotic surgery

The summit is a good place to be

July 1, 2023

pAQ monitor: innovative device provides real-time surveillance of SARS-CoV-2 aerosols

Researchers presented the proof-of-concept of a pathogen Air Quality (pAQ) monitor.

July 13, 2023

Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer | Psychedelic Invest

Vancouver, British Columbia – October 24, 2024 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6), (the “Company” or “MindBio”), a leading biopharmaceutical company in psychiatric medicine development, targeting depressive

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.